Bio-Rad Laboratories
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	$2.92B N/A	$2.80B -4.11%	$2.67B -4.67%	Avg: $2.78B Low: $2.78B High: $2.78B avg. 4.14%	Avg: $2.88B Low: $2.88B High: $2.88B avg. 3.62%	Avg: $3.06B Low: $3.06B High: $3.06B avg. 6.38%
Net Income % change YoY	$4.25B N/A	$-3.62B -185.26%	$-637.32M 82.43%	Avg: $347.44M Low: $347.44M High: $347.44M avg. 154.51%	Avg: $396.94M Low: $396.94M High: $396.94M avg. 14.24%	Avg: $481.94M Low: $481.94M High: $481.94M avg. 21.41%
EBITDA % change YoY	$650.00M N/A	$664.48M 2.22%	$-608.26M -191.53%	Avg: $594.95M Low: $594.95M High: $594.95M avg. 197.81%	Avg: $616.50M Low: $616.50M High: $616.50M avg. 3.62%	Avg: $655.86M Low: $655.86M High: $655.86M avg. 6.38%
EPS % change YoY	$142.61 N/A	-$121.79 -185.40%	-$21.82 82.08%	Avg: $11.9 Low: $11.9 High: $11.9 avg. 154.51%	Avg: $13.59 Low: $13.59 High: $13.59 avg. 14.24%	Avg: $16.5 Low: $16.5 High: $16.5 avg. 21.41%
Operating Expenses % change YoY	$1.15B N/A	$1.08B -5.77%	$1.08B 0.40%	Avg: $876.17M Low: $876.17M High: $876.17M avg. -19.55%	Avg: $907.90M Low: $907.90M High: $907.90M avg. 3.62%	Avg: $965.88M Low: $965.88M High: $965.88M avg. 6.38%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 63.39% in 2025-2027.

We have gathered data from N/A analysts. Their low estimate is 347.44M, average is 347.44M and high is 347.44M.

Wall Street analysts forecast annual average revenue growth of 4.71% in 2025-2027.

We have gathered data from N/A analysts. Their low revenue estimate is $2.78B, average is $2.78B and high is $2.78B.

Wall Street analysts forecast annual average earnings growth of 63.39% in 2025-2027.

We have gathered data from N/A analysts. Their low earnings per share estimate is $11.9, average is $11.9 and high is $11.89.